BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33994447)

  • 1. Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
    Kidoguchi K; Kubota Y; Fujimoto S; Sakata Y; Kizuka-Sano H; Yamaguchi K; Ureshino H; Katsuya H; Ando T; Esaki M; Kimura S
    Intern Med; 2021; 60(10):1601-1605. PubMed ID: 33994447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
    Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
    Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
    Passweg JR
    Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome.
    Conrad ME; Barton JC
    Am J Hematol; 1979; 7(1):61-7. PubMed ID: 507047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancytopenia in a Case of Aplastic Anaemia/Paroxysmal Nocturnal Haemoglobinuria Unmasked by SARS-CoV-2 Infection: A Case Report.
    Iannuzzi A; Parrella A; De Ritis F; Cammarota A; Berloco L; Paudice F; D'Angelo G; Aliberti E; Iannuzzo G
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.
    Schulte S; Kütting F; Mertens J; Kaufmann T; Drebber U; Nierhoff D; Töx U; Steffen HM
    BMC Gastroenterol; 2019 Feb; 19(1):36. PubMed ID: 30813906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paroxysmal nocturnal hemoglobinuria and aplastic anemia].
    Thollot F; Bordigoni P; Olive D
    Arch Fr Pediatr; 1984 Mar; 41(3):197-200. PubMed ID: 6742973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Inoue N
    Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome".
    Ray S; Marwaha N; Sarode R
    Indian J Pathol Microbiol; 1989 Jul; 32(3):240-2. PubMed ID: 2777356
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: A single-center experience in Saudi Arabia.
    AlGhasham N; Abulkhair Y; Khalil S
    Cytometry B Clin Cytom; 2015; 88(6):389-94. PubMed ID: 26296648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), with special reference to aplastic anemia-PNH syndrome].
    Takahashi R
    Nihon Rinsho; 1978 Jul; 36(7):2740-5. PubMed ID: 702866
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
    Rizk S; Ibrahim IY; Mansour IM; Kandil D
    J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated varicella-zoster virus infection in an aplastic anemia- paroxysmal nocturnal hemoglobinuria syndrome patient: A case report.
    Wang J; Yang Z; Ren D; Shi Z; Fang K; Li Z
    Front Cell Infect Microbiol; 2023; 13():1163872. PubMed ID: 37153152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Groth M; Singer S; Niedeggen C; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
    Ann Hematol; 2017 Feb; 96(2):171-181. PubMed ID: 27837250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
    Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
    Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
    Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
    Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.
    Nowak J; Wozniak J; Mendek-Czajkowska E; Dlugokecka A; Mika-Witkowska R; Rogatko-Koros M; Graczyk-Pol E; Marosz-Rudnicka A; Dziopa J; Golec A; Kopec-Szlezak J; Warzocha K
    Cell Biochem Biophys; 2013 Apr; 65(3):321-33. PubMed ID: 23076633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis.
    Wang B; He B; Zhu YD; Wu W
    Hematology; 2020 Dec; 25(1):464-472. PubMed ID: 33269994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria in childhood: an uncommon presentation.
    Gupta V; Tilak V; Ramakrishna SV; Bhatia BD
    Indian J Med Sci; 2006 Feb; 60(2):64-7. PubMed ID: 16505576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosomy 7 in patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria with evolution into acute myeloid leukemia.
    Auewarakul CU; Tocharoentanaphol C; Wanachiwanawin W; Issaragrisil S
    J Med Assoc Thai; 2004 Jun; 87(6):717-21. PubMed ID: 15279356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.